• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Dockhorn joins SCORR Marketing

Dockhorn joins SCORR Marketing

June 13, 2013
CenterWatch Staff

Michelle Dockhorn, M.B.A., Ph.D., an executive with extensive marketing and business development leadership experience specific to the life science industry, has joined SCORR Marketing as vice president of global markets. Dockhorn brings 20 years of experience to SCORR.

“Michelle has worked with organizations around the world, from startups to some of the biggest companies in this industry,” said Cinda Orr, SCORR president and chief executive officer. “By applying her vast experience, she has helped them build dynamic marketing programs, increase their sales and grow their businesses. Michelle understands the complexities of the drug development services industry, and our clients will find her knowledge and experience to be a great resource.”

Dockhorn began her career in drug development with National Medical Research (now SciRex), in data management, statistics, medical writing and quality assurance. She was a clinical scientist for Bristol-Myers Squibb before joining PRA, where she became vice president of global business development.

Dockhorn has served as an executive consultant in marketing, sales and business development roles for several companies in the drug development services industry, including Focus Bio-Inova, Nextrials, Logical Therapeutics, CR and Trio Clinical Research, which has since become a part of Aptiv Solutions.

 

Upcoming Events

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • MachineLearning-360x240.png

    Industry Using AI/ML to Improve Data, Quality and Trial Management, Survey Says

  • VirtualTraining-360x240.png

    Virtual Training Evolves into More In-Depth Learning, Improved Communications

  • SurveywBlueBackground-360x240.png

    Mid-Study Updates Delay Trials At Least a Month, CSDD Report Finds

  • Real-TimeData-360x240.png

    Real-Time Data Helped Sponsors Respond to Sites’ Needs During the Pandemic

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing